Proprietary formulas hide ingredient-level dose detail, which reduces transparency for both safety and optimization decisions.
Why it matters
Without per-ingredient grams, duplicate detection and interaction screening become less precise.
Transparency tradeoff
Lower label transparency means lower confidence around:
- true active dose per ingredient
- contamination or substitution risk
- stacking math with overlapping compounds
Impact on safety checks
Safety systems may keep more conservative ceilings when proprietary formulas are used because exact overlap cannot be confirmed.
Practical action rule
Avoid proprietary formulas when you need clinical tracking or symptom attribution.
If you already use one, log it as a single high-uncertainty unit and reduce simultaneous overlap with related ingredients.
Uncertainty and limits
- Evidence is limited on ingredient-level effects for most proprietary formulas in controlled settings.
- Evidence is limited on long-term outcome reliability when dosage transparency is absent.
Cross-site references
How this appears in Unfair
The platform may apply stricter duplicate and interaction assumptions and reduce ranking confidence for proprietary formulas.
Clinical safety note
Treat proprietary formulas as high-uncertainty sources and prefer clinician-guided oversight for complex or high-risk stacks.